KALY - Kali, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.0069
-0.0005 (-6.76%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close0.0074
Open0.0073
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0067 - 0.0079
52 Week Range0.0002 - 0.0393
Volume11,529,353
Avg. Volume9,153,660
Market Cap664,071
Beta (3Y Monthly)-49.07
PE Ratio (TTM)0.00
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
All
News
Press Releases
  • GlobeNewswire

    KALY – Kali-Extracts Is Making CBD Infused Coffee

    DALLAS, Oct. 11, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (KALY) (“KALY”) today announced today announced that as part of the sole license it has granted to Puration, Inc. (PURA) for use of the KALY U.S. Patented Cannabis Extraction Process for the production of beverages, KALY has recently been engaged by PURA to design a coffee infusion process.

  • GlobeNewswire

    PURA – Puration Announces CBD Infused Fair Trade Coffee From Kenya

    PURA currently makes and sells EVERx CBD Sports Water, the leading CBD sports drink in the sports nutrition market.  PURA has reported over $1 million in CBD beverage sales in the first six months of 2019 after reporting approximately $1 million in sales for all of 2018.  On top of its ongoing sales, PURA has signed a new European distribution agreement anticipated to generate $4 million annually with a first shipment scheduled later this month. A few months ago, PURA launched an initiative to partner with other beverage companies and introduce CBD Infused beer, coffee and tea beverages.  As part of the initiative, PURA engaged Goldman Small Cap Research to conduct a CBD beverage industry survey (see link below).  Yesterday, Goldman published the final survey results of the survey.

  • GlobeNewswire

    KALY – Kali-Extracts Announces Exploding Demand For Its CBD Extraction Services

    DALLAS, Oct. 10, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (KALY) (“KALY”) today announced what it referred to as “exploding” demand for its CBD extraction services.  KALY has already begun harvesting its first hemp crop in the state of New York signed under a consignment contract worth a potential $5 million.  Word is out on KALY’s process and KALY is receiving what it characterizes as “non-stop” calls for extraction services.  “The hemp harvesting season has hit and I think some of the first-time hemp farmers are realizing now that they don’t’ have the equipment to extract CBD from hemp,” said Frederick Ferri, CEO of KALY. “The equipment is expensive and even if you’ve got the funds, good luck finding the equipment now.”  The State of New York alone, where KALY is already working, has a reported 18,000 acers of hemp in just the Hudson Valley area.

  • GlobeNewswire

    PURA – Puration Prospects Rise With Cannabis Legalization 2.0

    DALLAS, Oct. 09, 2019 -- via OTC PR WIRE – Puration, Inc. (USOTC: PURA) today revealed the recent increase in inquiries it is receiving from cannabis businesses in Canada.

  • GlobeNewswire

    KALY – Kali-Extracts Developing OTC and Prescription CBD Treatments

    DALLAS, Oct. 08, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (KALY) (“KALY”) today confirmed the company is pursuing the development of Over-The-Counter (OTC) and prescription CBD treatments.  The company yesterday released an update on its latest Cannabis Extract Biopharmaceutical developments.  The information from yesterday’s release to include the specifics on the OTC and prescription CBD treatments is contained here in today’s release.

  • PR Newswire

    KALY - Kali-Extracts Cannabis Extract Biopharmaceutical Developments Validate $0.05 Analyst PPS Target

    DALLAS, Oct. 7, 2019 /PRNewswire/ -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (KALY) ("KALY") today released an update on the company's latest Cannabis Extract Biopharmaceutical developments. KALY has implemented a sustainable strategy to develop cannabis extracts from its US Patented Cannabis Extraction Process to treat a variety of specific health issues. In light of the long-term commitment to the biopharmaceutical development process and the corresponding requirement for continuous fund raising through the process, KALY has implemented a parallel business strategy to more immediately monetize its patented intellectual property through consumer applications of its technology.

  • GlobeNewswire

    KALY – Kali-Extracts Q4 Revenue Jump Anticipated From CBD Extraction Contracts

    DALLAS, Oct. 04, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (KALY) (“KALY”) today announced an anticipated jump in revenue in Q4 2019 related to the company’s CBD extraction contracts with hemp farming operations currently underway now that the hemp harvest season is in full swing.  The company has announced hemp extraction contracts worth a potential $15 million in revenue.  While not all that revenue will be realized in one quarter, management still anticipates a substantial jump in revenue in Q4 over previous recent quarters. The company has schedule a presentation for next week on Monday, October 7, 2019 to communicate its latest Cannabis Extract Biopharmaceutical developments.  The presentation will also include updates on the company’s consumer cannabis extract business which is growing rapidly through its licensing business with Puration, Inc. (PURA), the sale of its own CBD infused candies under its in house Hemp4mula brand, and through its direct CBD extraction contracts with hemp farming operations mentioned above.

  • GlobeNewswire

    KALY – Kali-Extracts Confirms CBD Extract Biopharmaceutical Business Update Scheduled Monday October 7, 2019

    DALLAS, Oct. 03, 2019 -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today confirmed the company has schedule a.

  • GlobeNewswire

    KALY – Kali-Extracts Consumer Cannabis Extract Business Reports Growing Revenue Bolstering Its Long Term Biopharmaceutical Strategy

    DALLAS, Oct. 01, 2019 -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today highlighted the progress of Puration, Inc..

  • GlobeNewswire

    PURA – Puration Enters $1.7 Billion European CBD Market With New Distribution Agreement For Its EVERx CBD Sports Water

    DALLAS, Oct. 01, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Puration, Inc. (PURA) today released a presentation detailing its recently announced new distribution agreement for its EVERx CBD Sports Water in Europe anticipated to generate $4 million in annual revenue. Two weeks ago, PURA kicked off a European marketing campaign for its EVERx CBD Sports Water at Arnold Schwarzenegger’s Arnold Sports Festival Europe in Barcelona.

  • GlobeNewswire

    KALY – Kali-Extracts Cannabis Extract Biopharmaceutical Business Strides Forward

    DALLAS, Sept. 30, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (KALY) (“KALY”) today announced an update from CEO Frederick Ferri on the company’s continuing Cannabis Extract Biopharmaceutical developments scheduled for next week on Monday, October 7, 2019.  The last Cannabis Extract Biopharmaceutical developments update was issued over one month ago.  The company has made some substantial strides forward since that time and looks forward to sharing the progress with shareholders. In the fourth quarter of last year, 2018, KALY acquired NCMB.

  • GlobeNewswire

    KALY – Kali Extracts Patented Cannabis Extraction Process Used To Develop $13 Billion Market Foothold By NOUV

    DALLAS, Sept. 27, 2019 -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced its U.S. Patented Cannabis.

  • GlobeNewswire

    PURA and NOUV Announce Cannabis Cultivation Business Update To Include Latest On Planned Dividend and KALY Extraction Partnership

    DALLAS, Sept. 26, 2019 -- via OTC PR WIRE -- Puration, Inc. (USOTC: PURA) (“PURA”) and Nouveau, Inc. (aka Nouveau Life Pharmaceuticals) (USOTC: NOUV) (“NOUV”) today announced a.

  • GlobeNewswire

    KALY – Kali-Extracts Announces New CBD Extract For TranquiliTeaCBD From Puration

    DALLAS, Sept. 25, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (KALY) (“KALY”) today announced a new CBD Extract Formula for Puration’s (PURA) recently announced TranquiliTeaCBD.  PURA owns the sole license of KALY’s U.S. Patented Cannabis Extraction Process for the purposes of producing cannabis extracts for infusion into beverages.  PURA works closely with KALY in the management of the extraction process particularly when it comes to designing new extracts for designer drinks.  PURA yesterday announced its new CBD infused beverage, TranquiliTeaCBD. TranquiliTeaCBD is on track to be available for sale to consumers by year end see (www.TranquiliTeaCBD.com).

  • GlobeNewswire

    PURA – Puration Anticipates First Major EVERx CBD Sports Water Order In Europe Later This Week Coming From Arnold Sports Festival In Barcelona

    DALLAS, Sept. 24, 2019 -- via OTC PR WIRE -- Puration, Inc. (USOTC: PURA) today announced that the company anticipates is first major order of EVERx CBD Sports Water order.

  • GlobeNewswire

    KALY – Kali-Extracts Announces CBD Derived Hemp Extraction Orders Rolling-In With First Legal Harvest Season

    DALLAS, Sept. 24, 2019 -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced receiving a dramatic number of hemp.

  • PR Newswire

    KALY - Kali-Extracts First Hemp Harvest With Anticipated $5 M Revenue Potential Expected to Boost Q4 Sales Substantially

    DALLAS , Sept. 20, 2019 /PRNewswire/ -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) ("KALY") today announced an anticipated substantial increase in sales in Q4 2019 ...

  • PURA – Puration is One Step Ahead of US Aurora Cannabis Hemp Derived CBD Strategy
    GlobeNewswire

    PURA – Puration is One Step Ahead of US Aurora Cannabis Hemp Derived CBD Strategy

    DALLAS, Sept. 17, 2019 -- via OTC PR WIRE – Puration, Inc. (USOTC: PURA) (”PURA”) today complimented Aurora Cannabis on its strategy to pursue the legal hemp derived CBD market.

  • KALY – Kali-Extracts Announces First Hemp Harvest
    GlobeNewswire

    KALY – Kali-Extracts Announces First Hemp Harvest

    DALLAS, Sept. 16, 2019 -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced its first hemp harvest has begun..

  • GlobeNewswire

    KALY – Kali-Extracts Continues Cannabinoid Testing For CBD Extraction Contract Worth Anticipated $5 Million

    DALLAS, Sept. 13, 2019 -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced its continued cannabinoid testing.

  • GlobeNewswire

    KALY – Kali-Extracts Confirms OTC CBD Extract Drug Certification Initiative – See Presentation September 17, 2019

    DALLAS, Sept. 11, 2019 -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today confirmed a scheduled presentation to outline.

  • GlobeNewswire

    KALY – Kali-Extracts Plans To Certify CBD Extract As OTC Drug Under FDA Requirements

    DALLAS, Sept. 10, 2019 -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced a scheduled presentation to outline.

  • GlobeNewswire

    PURA – Puration Begins Pre-Marketing CBD Infused Beer Coffee and Tea

    DALLAS, Sept. 09, 2019 -- via OTC PR WIRE – Puration, Inc. (USOTC: PURA) (”PURA”) today announced the company has launched a pre-marketing campaign of its new CBD Infused beer,.

  • GlobeNewswire

    KALY – Kali-Extracts Receives Proposal To Certify Its CBD Extract As OTC Drug Under FDA Requirements

    A recent analyst report from Goldman Small Cap Research published last week covering KALY’s recent biopharmaceutical cannabis extract business development updates has now been updated to the company’s website.  The report can be found in its entirety on Goldman’s website www.goldmanresearch.com and on the company’s website, www.kali-extracts.com/analyst-rpt.  The report speculates a potential KALY price per share of $0.05.

  • GlobeNewswire

    KALY- Kali-Extracts Analyst Report Speculating $0.05 PPS On Recent Biopharmaceutical Cannabis Extract Progress Updated To Website

    DALLAS, Sept. 03, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (KALY) (“KALY”) today announced the analyst report from Goldman Small Cap Research published last week covering the KALY’s recent biopharmaceutical cannabis extract business development updates has now been updated to the company’s website.  The report can be found in its entirety on Goldman’s website www.goldmanresearch.com and on the company’s website, www.kali-extracts.com/analyst-rpt.  The report speculates a potential KALY price per share of $0.05.